Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging

18Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Background: While many studies have shown that hormones can influence background parenchymal enhancement (BPE) in breast magnetic resonance imaging (MRI), only few have directly address the effect of radiotherapy. The purpose of this study was to evaluate the impact of radiotherapy on BPE in breast MRI. Materials and Methods: A retrospective search identified 62 women with unilateral breast cancer who had a breast MRI both before and after radiotherapy following breast-conserving surgery. In our study, we assumed that systemic therapy affected both breasts equivalently. We rated the level of BPE of both breasts using a fourpoint categorical scale. A change in the level of BPE prior to and after treatment was compared in the diseased and contralateral breasts. Results: All patients received a 4256 to 6480 cGy dose of whole breast radiotherapy over 3-7 weeks. The mean timing of the follow-up study was 6.6 months after completion of radiotherapy. Although the BPE showed a decrease in both breasts after treatment, there was a significant reduction of BPE in the irradiated breast compared with the contralateral breast (1.18 versus 0.98 average reduction in BPE level, p=0.042). Conclusions: Radiotherapy is associated with decrease in BPE with MRI.

Cite

CITATION STYLE

APA

Kim, Y. J., Kim, S. H., Choi, B. G., Kang, B. J., Kim, H. S., Cha, E. S., & Song, B. J. (2014). Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging. Asian Pacific Journal of Cancer Prevention, 15(7), 2939–2943. https://doi.org/10.7314/APJCP.2014.15.7.2939

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free